Parkinson's disease affects approximately 1–2% of the South African population over 60, and with SA's ageing demographic, prevalence is increasing. It is slightly more common in men. While traditionally considered a disease of European populations, all South African ethnic groups are affected, though diagnosis rates remain lower in rural areas and underserved communities due to limited access to neurology services.
The condition involves the progressive loss of dopamine-producing neurons in the substantia nigra, causing the classical motor symptoms: tremor, rigidity, bradykinesia (slowness of movement), and postural instability. Non-motor symptoms — depression, cognitive impairment, sleep disorders, constipation, and autonomic dysfunction — are equally important and have significant nutritional implications.
Unintentional weight loss affects an estimated 50–65% of Parkinson's patients over the course of the disease. It is associated with faster disease progression and poorer outcomes. Understanding why is key to addressing it:
Tremor, dyskinesia (involuntary movements sometimes caused by levodopa), and rigidity all increase energy expenditure significantly. Research shows that moderate-to-severe dyskinesia can increase caloric needs by 200–500 calories per day above baseline. Patients are effectively "exercising" involuntarily throughout the day.
Parkinson's affects the muscles controlling swallowing in up to 80% of patients at some stage. This leads to eating less, avoiding certain textures, and in severe cases, aspiration risk. A speech therapist assessment is important if you notice coughing, choking, or difficulty with certain foods. Softer, calorie-dense foods may be needed.
Loss of smell (anosmia) is one of the earliest Parkinson's symptoms, often predating motor symptoms by years. Reduced olfactory input dramatically decreases the pleasure and motivation of eating, reducing food intake. Depression (extremely common in Parkinson's) further reduces appetite.
Levodopa-based medications commonly cause nausea (especially early in treatment), constipation, and delayed gastric emptying (gastroparesis). Constipation affects virtually all Parkinson's patients to some degree, causing discomfort that reduces appetite and food intake.
While weight loss is the more common concern, weight gain occurs in specific situations:
Dopamine agonists (pramipexole/Mirapex, ropinirole) can trigger impulse control disorders in 13–17% of patients, including compulsive eating (binge eating disorder). Patients describe being unable to stop eating — particularly highly palatable, high-calorie foods — as a compulsion they cannot control. If this is happening, report it to your neurologist immediately. Medication adjustment or dose reduction can resolve it.
Before significant motor symptoms develop, patients may dramatically reduce physical activity out of fear or fatigue, while food intake remains the same. Weight gain in this phase is manageable through structured gentle exercise.
This is the most important nutritional consideration for Parkinson's patients on levodopa (Sinemet, Stalevo, Madopar — all available in SA):
| Strategy | How to Do It | Best For |
|---|---|---|
| Low-protein daytime, higher-protein evening | Eat most protein at dinner (after your last levodopa dose, or when motor control matters less) | Patients with significant motor fluctuations during the day |
| Take levodopa 30–60 min before meals | On an empty stomach with water; eat meal after absorption window | All levodopa patients — maximises absorption |
| Protein redistribution diet | Limit protein to 7g per meal during the day; eat remaining protein allowance at evening meal | Patients with severe midday motor fluctuations |
| Consistent protein per meal | Spread protein evenly — avoids spikes that compete with levodopa | Patients with mild fluctuations |
The Mediterranean diet has the strongest evidence for Parkinson's management. A 2021 study in Movement Disorders found Mediterranean diet adherence associated with slower cognitive decline and better motor outcomes. Key components:
Constipation is one of the most distressing non-motor Parkinson's symptoms. Nutritional management:
Exercise is one of the most powerful interventions in Parkinson's management — evidence suggests it may slow disease progression by promoting neuroplasticity. The key is exercise during "on" periods when medication is working.
| Activity | Evidence | SA Availability |
|---|---|---|
| Tango dancing | Strong RCT evidence for gait, balance, freezing of gait | Parkinson's tango classes in Cape Town, Johannesburg, Durban — PASA can refer |
| Tai chi | Strong evidence for balance and fall prevention | Many community centres and gyms; free videos on YouTube |
| Cycling (stationary or outdoor) | Strong evidence; forced-pace cycling at 80–90 RPM especially effective | Home stationary bikes R2,000–R5,000; gym availability nationwide |
| Rock Steady Boxing | Non-contact boxing; strong evidence for motor symptoms | Available in Johannesburg, Cape Town, Durban — contact PASA |
| Swimming / hydrotherapy | Good for fall risk; buoyancy reduces injury risk | Municipal pools, CHC hydrotherapy pools in some areas |
| Resistance training | Preserves muscle mass; improves functional capacity | Home weights, gym, or physiotherapy-guided |
| Walking (brisk) | Moderate evidence; use walking poles for stability | Accessible everywhere; Nordic walking poles R200–R400 |
Yes — unintentional weight loss affects 50–65% of Parkinson's patients. Tremor and dyskinesia burn extra calories, dysphagia reduces food intake, depression and anosmia reduce appetite, and levodopa causes nausea. Weight loss in Parkinson's is associated with faster disease progression and needs proactive nutritional management.
Levodopa competes with dietary protein-derived amino acids for absorption. Taking levodopa with a high-protein meal can reduce its effectiveness by 30–40%. Take levodopa 30–60 minutes before or after protein-containing meals, and avoid eating most of your daily protein in the morning when motor control is most important.
Tango dancing, tai chi, cycling, Rock Steady Boxing, swimming, and resistance training all have strong evidence. Exercise during "on" periods (when medication is working) is most effective. A physiotherapist trained in Parkinson's management can create a personalised programme.
Yes — pramipexole and ropinirole can trigger compulsive eating (impulse control disorder) in 13–17% of patients. This manifests as uncontrollable binge eating, particularly of high-calorie foods. If this is happening, report it to your neurologist immediately — medication adjustment can resolve it.
Sources: Parkinson's Association of South Africa 2024 | Movement Disorders Society Clinical Practice Guideline | Barichella M et al, Nutrition 2017 | Okubo H et al, Movement Disorders 2019 | PASA Exercise Guidelines | South African Neurology Society | CDL/PMB Defined Benefits Schedule 2024. Last reviewed June 2026.